Recent research highlights the evolution of hypertrophic cardiomyopathy from a high-risk condition to a treatable disease with low mortality rates. This transformation is attributed to contemporary clinical research strategies that enhance treatment options.
evolution and transformation of hypertrophic cardiomyopathy from a high risk to a treatable low mortality disease with contemporary clinical research strategies
Original title: “Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies.”